399 related articles for article (PubMed ID: 35486310)
1. A raising dawn of pentoxifylline in management of inflammatory disorders in Covid-19.
Mostafa-Hedeab G; Al-Kuraishy HM; Al-Gareeb AI; Jeandet P; Saad HM; Batiha GE
Inflammopharmacology; 2022 Jun; 30(3):799-809. PubMed ID: 35486310
[TBL] [Abstract][Full Text] [Related]
2. Ursolic acid and SARS-CoV-2 infection: a new horizon and perspective.
Al-Kuraishy HM; Al-Gareeb AI; Negm WA; Alexiou A; Batiha GE
Inflammopharmacology; 2022 Oct; 30(5):1493-1501. PubMed ID: 35922738
[TBL] [Abstract][Full Text] [Related]
3. Repositioning of pentoxifylline as an immunomodulator and regulator of the renin-angiotensin system in the treatment of COVID-19.
Maldonado V; Loza-Mejía MA; Chávez-Alderete J
Med Hypotheses; 2020 Nov; 144():109988. PubMed ID: 32540603
[TBL] [Abstract][Full Text] [Related]
4. Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the
López-Iranzo FJ; López-Rodas AM; Franco L; López-Rodas G
Curr Pharm Des; 2020; 26(35):4515-4521. PubMed ID: 32787748
[TBL] [Abstract][Full Text] [Related]
5. Potential usefulness of pentoxifylline, a non-specific phosphodiesterase inhibitor with anti-inflammatory, anti-thrombotic, antioxidant, and anti-fibrogenic properties, in the treatment of SARS-CoV-2.
González-Pacheco H; Amezcua-Guerra LM; Sandoval J; Arias-Mendoza A
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7494-7496. PubMed ID: 32706089
[TBL] [Abstract][Full Text] [Related]
6. Covid-19 and development of heart failure: mystery and truth.
Onohuean H; Al-Kuraishy HM; Al-Gareeb AI; Qusti S; Alshammari EM; Batiha GE
Naunyn Schmiedebergs Arch Pharmacol; 2021 Oct; 394(10):2013-2021. PubMed ID: 34480616
[TBL] [Abstract][Full Text] [Related]
7. Mechanics Insights of Alpha-Lipoic Acid against Cardiovascular Diseases during COVID-19 Infection.
Rochette L; Ghibu S
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360751
[TBL] [Abstract][Full Text] [Related]
8. Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19.
Al-Kuraishy HM; Al-Gareeb AI; Mostafa-Hedeab G; Kasozi KI; Zirintunda G; Aslam A; Allahyani M; Welburn SC; Batiha GE
Front Immunol; 2021; 12():749291. PubMed ID: 34867978
[TBL] [Abstract][Full Text] [Related]
9. Pentoxifylline: A Drug with Antiviral and Anti-Inflammatory Effects to Be Considered in the Treatment of Coronavirus Disease 2019.
Ghasemnejad-Berenji M; Pashapour S; Sadeghpour S
Med Princ Pract; 2021; 30(1):98-100. PubMed ID: 33049737
[TBL] [Abstract][Full Text] [Related]
10. Treatment of COVID-19 with pentoxifylline: Could it be a potential adjuvant therapy?
Seirafianpour F; Mozafarpoor S; Fattahi N; Sadeghzadeh-Bazargan A; Hanifiha M; Goodarzi A
Dermatol Ther; 2020 Jul; 33(4):e13733. PubMed ID: 32473070
[TBL] [Abstract][Full Text] [Related]
11. The role of berberine in Covid-19: potential adjunct therapy.
Babalghith AO; Al-Kuraishy HM; Al-Gareeb AI; De Waard M; Al-Hamash SM; Jean-Marc S; Negm WA; Batiha GE
Inflammopharmacology; 2022 Dec; 30(6):2003-2016. PubMed ID: 36183284
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 and L-arginine Supplementations: Yet to Find the Missed Key.
Al-Kuraishy HM; Al-Gareeb AI; Alexiou A; Batiha GE
Curr Protein Pept Sci; 2022; 23(3):166-169. PubMed ID: 35549865
[TBL] [Abstract][Full Text] [Related]
13. Hypothesis: Pentoxifylline is a potential cytokine modulator therapeutic in COVID-19 patients.
Hendry BM; Stafford N; Arnold AD; Sangwaiya A; Manglam V; Rosen SD; Arnold J
Pharmacol Res Perspect; 2020 Aug; 8(4):e00631. PubMed ID: 32715661
[TBL] [Abstract][Full Text] [Related]
14. Flavonoids against the SARS-CoV-2 induced inflammatory storm.
Liskova A; Samec M; Koklesova L; Samuel SM; Zhai K; Al-Ishaq RK; Abotaleb M; Nosal V; Kajo K; Ashrafizadeh M; Zarrabi A; Brockmueller A; Shakibaei M; Sabaka P; Mozos I; Ullrich D; Prosecky R; La Rocca G; Caprnda M; Büsselberg D; Rodrigo L; Kruzliak P; Kubatka P
Biomed Pharmacother; 2021 Jun; 138():111430. PubMed ID: 33662680
[TBL] [Abstract][Full Text] [Related]
15. Cholinergic dysfunction in COVID-19: frantic search and hoping for the best.
Nadwa EH; Al-Kuraishy HM; Al-Gareeb AI; Elekhnawy E; Albogami SM; Alorabi M; Batiha GE; De Waard M
Naunyn Schmiedebergs Arch Pharmacol; 2023 Mar; 396(3):453-468. PubMed ID: 36460816
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant, Anti-inflammatory, and Immunomodulatory Roles of Nonvitamin Antioxidants in Anti-SARS-CoV-2 Therapy.
Pisoschi AM; Iordache F; Stanca L; Gajaila I; Ghimpeteanu OM; Geicu OI; Bilteanu L; Serban AI
J Med Chem; 2022 Oct; 65(19):12562-12593. PubMed ID: 36136726
[TBL] [Abstract][Full Text] [Related]
17. An overview of possible pivotal mechanisms of Genistein as a potential phytochemical against SARS-CoV-2 infection: A hypothesis.
Jafari A; Esmaeilzadeh Z; Khezri MR; Ghasemnejad-Berenji H; Pashapour S; Sadeghpour S; Ghasemnejad-Berenji M
J Food Biochem; 2022 Oct; 46(10):e14345. PubMed ID: 35866873
[TBL] [Abstract][Full Text] [Related]
18. Harnessing adenosine A2A receptors as a strategy for suppressing the lung inflammation and thrombotic complications of COVID-19: Potential of pentoxifylline and dipyridamole.
DiNicolantonio JJ; Barroso-Aranda J
Med Hypotheses; 2020 Oct; 143():110051. PubMed ID: 32650197
[TBL] [Abstract][Full Text] [Related]
19. Do inflammaging and coagul-aging play a role as conditions contributing to the co-occurrence of the severe hyper-inflammatory state and deadly coagulopathy during COVID-19 in older people?
Xu K; Wei Y; Giunta S; Zhou M; Xia S
Exp Gerontol; 2021 Aug; 151():111423. PubMed ID: 34048906
[TBL] [Abstract][Full Text] [Related]
20. Colchicine in the management of Covid-19: With or lieu of evidence.
Al-Kuraishy HM; Hussien NR; Al-Niemi MS; Al-Gareeb AI
J Pak Med Assoc; 2021 Dec; 71(Suppl 8)(12):S127-S132. PubMed ID: 35130235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
